skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical selected for government funding for DWN12088, a new medication for pulmonary fibrosis.
Date 2019-03-08 Hit 1137
News List
Prev Daewoong Pharmaceutical exceeds 1 trillion KRW in 2018 to reset the record.
Next Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia